For the Inventor, By the Inventor

Enter assignee name

Lafayette, CO, United States of America

Dharmacon, Inc.

USPTO Granted Patents = 115

CIPO Patents = 5

EPO Patents = 11

Trademarks = 15

Forward Citations = 4,092

Loading Chart...

Loading Chart...

41 inventors (with patents filed for the assignee):

Devin Leake (112 out of 135 patents)

Anastasia Khvorova (111 out of 202 patents)

William Marshall (107 out of 138 patents)

4. Angela Reynolds (103 out of 126 patents)

5. Stephen Scaringe (102 out of 123 patents)

6. Steven Read (97 out of 118 patents)

7. Barbara Robertson (6 out of 6 patents)

8. Christina Yamada (5 out of 6 patents)

9. Annaleen Vermeulen (4 out of 6 patents)

10. Kathryn Robinson (3 out of 3 patents)

11. Rob Kaiser (2 out of 5 patents)

12. Emily Anderson (2 out of 3 patents)

13. Joshua Stahl (1 out of 9 patents)

14. Brady Culver (1 out of 6 patents)

15. Abel Licon (1 out of 1 patent)

Core Competencies:

Gene Silencing

RNA Interference

siRNA Targeting

Duplex Oligonucleotides

Biotherapeutic Production

Polynucleotide Synthesis

Micro-RNA Clusters

Enhanced Functionality

Cyclin-Dependent Kinase

Apolipoprotein Targeting

Connective Tissue Growth Factor

Cellular Response Determination

115 patents: Sort by Forward Citations

1. 9988625 - Templates, libraries, kits and methods for generating molecules (2018-06-05),

2. 8501706 - Duplex oligonucleotide complexes and methods for gene silencing by RNA interference (2013-08-06),

3. 8461326 - SiRNA targeting connective tissue growth factor (CTGF) (2013-06-11),

4. 8445668 - SiRNA targeting apolipoprotein (APOB) (2013-05-21),

5. 8445667 - SiRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B) (2013-05-21),

6. 8426579 - SiRNA targeting myeloid differentiation primary response gene (88) (MYD88) (2013-04-23),

7. 8415466 - Duplex oligonucleotides with enhanced functionality in gene regulation (2013-04-09),

8. 8399654 - siRNA targeting catenin, Beat-1 (CTNNB1) (2013-03-19),

9. 8367318 - Screening of micro-RNA cluster inhibitor pools (2013-02-05),

10. 8314229 - siRNA targeting tie-2 (2012-11-20),

11. 8304528 - SiRNA targeting fructose-1, 6-bisphosphatase 1 (FBP1) (2012-11-06),

12. 8293887 - SiRNA targeting beta secretase (BACE) (2012-10-23),

13. 8273722 - Enhanced biotherapeutic production using inhibitory RNA (2012-09-25),

14. 8268985 - siRNA targeting amyloid beta (A4) precursor protein (APP) (2012-09-18),

15. 8252755 - Duplex oligonucleotide complexes and methods for gene silencing by RNA interference (2012-08-28),

Dharmacon, Inc. is a leading provider of RNA synthesis and gene-editing technologies. With a focus on serving the life sciences research community, Dharmacon offers innovative products and services that enable scientists to explore the functions and interactions of genes and RNA. Our broad range of high-quality RNAi reagents, CRISPR-Cas9 gene knockout and activation products, genetic screens, and custom RNA synthesis solutions empower researchers worldwide to uncover new insights in areas such as drug discovery, functional genomics, and personalized medicine.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

115 Patents

#1 in Lafayette, CO

#58 in Colorado

#3,209 in US

#6,683 in the World

Lafayette, CO, United States of America

Dharmacon, Inc.

Forward Citations = 4,092

41 inventors:

Devin Leake (112 out of 135 patents)

Anastasia Khvorova (111 out of 202 patents)

William Marshall (107 out of 138 patents)

4. Angela Reynolds (103 out of 126 patents)

5. Stephen Scaringe (102 out of 123 patents)

Please report any incorrect information to support@idiyas.com

Loading…